Solar Pharma, Alembic recall medication in US market – ET HealthWorld | Pharma

Solar Pharma, Alembic recall medication in US market – ET HealthWorld | Pharma

New Delhi: Home drug makers Solar Pharma and Alembic are recalling merchandise within the US market on account of manufacturing points, in keeping with the US Meals and Drug Administration (USFDA). As per the US well being regulator’s newest Enforcement Report, the Mumbai-based drug main is recalling 12,336 bottles of Buprenorphine Sublingual tablets, used for treating opioid use dysfunction, within the American market.

Solar Pharmaceutical Industries Inc, the US-based arm of the corporate, is recalling the affected lot (8 mg, 30 count-bottles) on account of CGMP (Present Good Manufacturing Apply) deviations, the USFDA acknowledged.

The corporate initiated the CLass II voluntary recall on Could 3 this 12 months.

Solar Pharma can also be recalling 7,313 bottles of Methylphenidate Hydrochloride tablets, used to deal with consideration deficit hyperactivity dysfunction, within the US market.

New Jersey-based Solar Pharmaceutical Industries Inc is recalling the lot as a result of “presence of international substance: metallic embedded in a pill”, the USFDA acknowledged.

The corporate initiated the recall on July 13 this 12 months, it added.

The US Well being regulator acknowledged that Alembic Prescription drugs is recalling 2,844 items of Diclofenac Sodium Topical Resolution within the American market.

The medicine is used to deal with ache and different signs of arthritis of the joints.

Alembic Prescription drugs Inc is recalling the affected lot on account of “faulty supply system”, USFDA stated. The corporate initiated the Class II recall on June 22 this 12 months.

As per the USFDA, a Class II recall is initiated in a state of affairs wherein use of, or publicity to, a violative product might trigger short-term or medically reversible antagonistic well being penalties or the place the likelihood of great antagonistic well being penalties is distant.

The Indian pharmaceutical business is the world’s third-largest by quantity and 14th-largest by way of worth. India exported prescription drugs value Rs 1,75,040 crore in 2021-22, together with bulk medication/ drug intermediates.

The US is the world’s largest marketplace for pharmaceutical merchandise.

  • Revealed On Jul 30, 2023 at 02:37 PM IST

Be part of the group of 2M+ business professionals

Subscribe to our e-newsletter to get newest insights & evaluation.

Obtain ETHealthworld App

  • Get Realtime updates
  • Save your favorite articles

Scan to obtain App

Supply hyperlink


Please enter your comment!
Please enter your name here